Pituitary tumor
Last updated: 7 September 2026
Reviewed by: Specialist doctors from the Elfcare quality team
Have you been experiencing persistent headaches, unexplained changes in your weight or energy levels, irregular periods, reduced libido, or changes in your peripheral vision that make it harder to see things to the side? Perhaps you have noticed gradual changes in your facial features, hands, or feet, or have been told that your blood pressure is difficult to control despite treatment. These symptoms can occur with a pituitary tumour, a growth in the pituitary gland that can affect the hormones involved in growth, metabolism, reproduction, and the body's response to stress.
Pituitary adenomas are among the more common tumours found in and around the brain. Most are benign and slow-growing, but their location can allow even relatively small tumours to affect hormone production or, when larger, compress nearby structures such as the optic chiasm. Early identification through MRI and a comprehensive hormonal blood panel is the most direct way to detect one.
Book a consultation now to test your health
What is pituitary tumor?
The pituitary gland is a pea-sized gland at the base of the brain that produces hormones involved in growth, metabolism, reproduction, and the body's response to stress. A pituitary tumour is an abnormal growth arising from the pituitary gland. Most pituitary tumours are benign adenomas rather than cancerous growths. Doctors classify pituitary adenomas according to their size and whether they produce excess hormones:
By size
Microadenoma (under 10 mm): small tumours that may produce excess hormones, although many cause no symptoms and are discovered incidentally.
Macroadenoma (10 mm or larger): larger growths that can squeeze the surrounding brain tissue, normal gland parts, or eye nerves.
By hormonal activity
Non-functioning: does not produce excess pituitary hormones and may cause symptoms mainly when it becomes large enough to affect nearby structures.
Prolactinoma: the most common type. It leaks excess prolactin, causing low sex drive, erectile dysfunction, or irregular periods.
Somatotroph: leaks growth hormone, causing parts of the body, like hands, feet, and face features, to enlarge.
Corticotroph: leaks the stress-signal hormone ACTH, triggering Cushing’s disease (weight gain, high blood pressure, and muscle weakness).
Thyrotroph and gonadotroph: rare types that leak thyroid-stimulating or reproductive hormones, though they often cause no hormone symptoms at all.
Symptoms of pituitary tumor
Symptoms depend on whether the tumour produces excess hormones and whether it grows large enough to affect nearby structures.
From hormonal excess
Prolactinoma: irregular or absent periods, milky nipple discharge, reduced libido, infertility, erectile dysfunction, and breast enlargement in men
Acromegaly (somatotroph adenoma): gradual enlargement of the hands, feet, and facial features, joint pain, excessive sweating, and carpal tunnel syndrome
Cushing's disease (corticotroph adenoma): produces excess ACTH, which can cause Cushing's disease. Symptoms may include central weight gain, a round face, purple stretch marks, easy bruising, muscle weakness, high blood pressure, and diabetes
Thyrotroph adenoma: symptoms of hyperthyroidism including weight loss, palpitations, and heat intolerance
From mass effect
Headaches
Bitemporal hemianopia, loss of peripheral vision on both sides, from optic chiasm compression
Double vision from cranial nerve compression in the cavernous sinus
Hypopituitarism, deficiency of one or more pituitary hormones from compression of normal pituitary tissue
What causes pituitary tumor?
The exact cause is not fully understood in most cases. Contributing factors include:
Genetic changes and inherited syndromes: acquired genetic changes in pituitary cells may contribute to sporadic adenomas. Inherited conditions such as multiple endocrine neoplasia type 1 (MEN1), familial isolated pituitary adenoma (FIPA), and Carney complex can increase the risk of developing pituitary adenomas. FIPA can be associated with mutations in the AIP gene.
Age: pituitary adenomas become more common with age, though they can occur at any age.
Gender: some types, particularly prolactinomas, are more common in women, especially during the reproductive years.
How is pituitary tumor detected?
Pituitary tumours are evaluated using a combination of dedicated pituitary MRI, hormonal blood tests, and clinical assessment.
Brain MRI Elfcare’s full-body MRI can visualise the pituitary gland and identify larger pituitary lesions. Dedicated pituitary MRI provides the highest level of detail for characterising small adenomas and their relationship to nearby structures.
Blood tests assess the pituitary hormonal axis, identifying both hormonal excess from functioning adenomas and hormonal deficiency from compression of normal pituitary tissue. Relevant markers in Elfcare's panel include:
Prolactin: high levels find the most common hormone-leaking tumor, which can impact fertility and sex drive.
IGF-1: acts as a stable marker to detect hidden growth hormone overproduction.
Cortisol: helps assess adrenal function when pituitary dysfunction or cortisol excess is suspected.
Thyroid panel (TSH, Free T3, Free T4): catches thyroid hormone imbalances caused by a direct tumor or gland compression.
LH, FSH, testosterone and oestradiol: checks for drops in reproductive and sex hormones caused by tumor pressure.
Sodium: screens for fluid control imbalances caused by pressure on the back part of the gland.
Why early detection matters
Finding a pituitary tumor early opens up the best treatment options and outcomes before permanent damage occurs. Some pituitary tumours, particularly prolactinomas, can be effectively treated with medication. Others may be monitored or require surgery, radiation therapy, or other specialist treatment depending on their size, hormonal activity, growth, and effect on surrounding structures. Prompt treatment of optic chiasm compression can improve the chance of recovering or preserving vision, although recovery depends on the severity and duration of compression.
How Elfcare can help
Elfcare's full body MRI images the pituitary gland directly as part of standard brain imaging, identifying pituitary adenomas and characterising their size, location, and relationship to adjacent structures. Our blood panel covers the pituitary hormonal axis including prolactin, IGF-1, cortisol, TSH, thyroid hormones, LH, FSH, and sex hormones, providing complementary structural and hormonal information that can help identify abnormalities requiring further evaluation.
The combination of imaging and hormonal testing can provide useful information when symptoms or other findings raise concern about pituitary dysfunction. Suspected pituitary abnormalities may require dedicated pituitary MRI and specialist endocrine assessment.
Summary
Pituitary tumours, most commonly benign pituitary adenomas, disrupt the hormonal signals regulating metabolism, reproduction, growth, and stress response through hormonal excess or by compressing adjacent pituitary tissue. Elfcare's full body MRI images the pituitary gland directly and our blood panel covers the pituitary hormonal axis including prolactin, IGF-1, cortisol, thyroid function, and gonadal hormones. Early identification of clinically significant pituitary tumours can allow appropriate treatment before hormonal, visual, or structural complications become more advanced. It provides the most favourable conditions for treatment that restores hormonal balance and protects long-term health and quality of life.
Last updated: 7 September 2026
Reviewed by: Specialist doctors from the Elfcare quality team
FAQ
-
A pituitary tumour is an abnormal growth arising from the pituitary gland, the small but critically important hormone-producing gland at the base of the brain. The most common type is a pituitary adenoma, a benign tumour arising from one cell type within the anterior pituitary. Adenomas are classified as microadenomas (less than 10 mm) or macroadenomas (10 mm or larger), and as functioning (producing excess hormones) or non-functioning (causing symptoms only through mass effect).
-
Symptoms depend on the tumour type and size. Prolactinomas cause menstrual irregularity, galactorrhoea, and reduced libido. Acromegaly causes gradual enlargement of hands, feet, and facial features. Cushing's disease causes central obesity, hypertension, and diabetes. Non-functioning macroadenomas cause headaches, bitemporal visual field loss from optic chiasm compression, and hypopituitarism from compression of normal pituitary tissue.
-
Most arise from somatic mutations causing clonal expansion of a single pituitary cell type without a hereditary cause. Multiple endocrine neoplasia type 1, familial isolated pituitary adenoma from AIP mutations, and Carney complex are the most important inherited causes. Age and female sex are additional contributing factors for specific subtypes.
-
Brain MRI directly images the pituitary gland, identifying adenomas and characterising their size and relationship to adjacent structures. A comprehensive hormonal blood panel covering prolactin, IGF-1, cortisol, thyroid function, LH, FSH, and sex hormones identifies hormonal excess from functioning adenomas and deficiency from compression of normal pituitary tissue.
-
Yes. Elfcare's full body MRI images the pituitary gland directly as part of standard brain imaging, and our blood panel covers the complete pituitary hormonal axis. The combination of structural MRI and comprehensive hormonal assessment makes Elfcare well positioned to identify both non-functioning macroadenomas and functioning microadenomas. If a pituitary tumour or hormonal abnormality is identified, we take care of further diagnostics or refer you to the appropriate specialist.
-
Yes. Treatment depends on tumour type and size. Prolactinomas are primarily treated with dopamine agonist medication, which normalises prolactin and shrinks the tumour in the majority of patients without surgery. Other functioning adenomas including those causing acromegaly and Cushing's disease are treated with transsphenoidal surgery, a minimally invasive approach through the nasal passage, achieving cure in the majority of microadenomas. Radiotherapy is used for residual or recurrent disease. Non-functioning macroadenomas are managed with surveillance or surgery when causing visual compromise or significant hormonal deficiency. Early identification consistently produces the best treatment outcomes across all pituitary tumour types.